我要投票 桂龙咳喘宁在医疗器械行业中的票数:65
· 外 推 电 报 ·
2025-01-19 03:05:36 星期日

【桂龙咳喘宁是哪个国家的品牌?】

桂龙咳喘宁是什么牌子?「桂龙咳喘宁」是桂龙药业(安徽)有限公司旗下著名品牌。该品牌发源于安徽省马鞍山市,由创始人Stephen John Coplin在2003-11-25期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

桂龙咳喘宁,知名咳嗽药品牌,成立于1989年,高新技术企业,中药呼吸系统和咽喉品类领域领先企业,集研发/生产/销售于一体的中药企业


桂龙药业成立于1989年,是集研发、生产、销售为一体的中药行业企业。桂龙,取自谐音“贵”“隆”,意为富贵华荣兴旺发达。且“桂”,有桂树四季翠绿,香飘万里而古朴典雅,是传统中药的化身;“龙”,象征着东方文化与蓄势勃发的力量。

公司拥有员工约1000人,总部位于福建省厦门市,在安徽省马鞍山市和山西省忻州市设有两个生产基地,总占地面积11万平方米,建筑面积近4万平方米,均为现代化的花园式GMP工厂。 桂龙药业在全国设立27个销售办事处,拥有500人的销售团队,销售人员有效管理近6万家零售终端门店,产品覆盖全国近三十万家零售药店,以及全国所有主流连锁药店。

2003年经当涂县委、县人大招商引资在当涂经济开发区征地120亩,投资5000万元,建立了一座符合GMP要求的生产企业——桂龙药业(安徽)有限公司。公司目前拥有国药准字号品种31个,主要生产经营范围为:片剂、胶囊剂、颗粒剂、煎膏剂、及生产加工、经营糖果。其主导产品主要有:慢严舒柠牌清喉利咽颗粒、桂龙咳喘宁胶囊、新生化颗粒、复方柴胡安神颗粒、好爽糖等。科技创新、管理创新、岗位创新、市场创新是企业发展的原动力。科技人员占员工比例36%以上。公司拥有的技术研发中心和检测中心,保障了公司科技的可持续发展,保障了药品的质量和药品的安全。

桂龙专注于中药呼吸系统和咽喉品类领域,创立了国内呼吸系统和咽喉领域两个品牌“桂龙”牌、“慢严舒柠”牌。

“有健康就有桂龙,桂龙药业、健康事业”是桂龙药业的宗旨;品牌战略、人才战略、创新战略是桂龙发展的三个支撑;“敬业”、“诚信”、“责任”、“创新”是桂龙发展的核心理念。随着企业的发展壮大,桂龙药业现有的生产与研发平台不足以支撑桂龙药业未来若干年的迅速持续发展,为此桂龙药业决定在当涂经开区征地数百亩,以国内专业的制药技术和工艺装备,打造一个集生物医药生产和研究开发于一体的现代化医药产业园,以此支撑桂龙未来十多年的长足发展和技术创新、科技进步。


英文翻译:Guilong Kechuanning, a famous cough medicine brand, was founded in 1989. It is a high-tech enterprise, a leading enterprise in the field of traditional Chinese medicine respiratory system and throat category. Guilong pharmaceutical, a traditional Chinese medicine enterprise integrating R & D, production and sales, was founded in 1989. It is a traditional Chinese Medicine enterprise integrating R & D, production and sales. Guilong, from the homonym "Gui" and "long", means prosperity and prosperity. And "Gui" is the embodiment of traditional Chinese medicine, which has four seasons of green, fragrant and elegant, and "long" symbolizes the power of Oriental culture and vigorous development. The company has about 1000 employees and its headquarter is located in Xiamen City, Fujian Province. It has two production bases in Maanshan City, Anhui Province and Xinzhou City, Shanxi Province, covering a total area of 110000 square meters and a building area of nearly 40000 square meters, all of which are modern garden GMP factories. Guilong pharmaceutical has 27 sales offices in China, with a sales team of 500 people. The sales staff effectively manage nearly 60000 retail terminal stores, covering nearly 300000 retail pharmacies and all mainstream chain pharmacies in China. In 2003, Dangtu County Party committee and County People's Congress invested 120 mu of land in Dangtu economic development zone and invested 50 million yuan to establish a GMP compliant production enterprise - Guilong Pharmaceutical (Anhui) Co., Ltd. At present, the company has 31 varieties of State Pharmaceutical quasi brand, the main production and business scope are: tablets, capsules, granules, decoctions, as well as the production, processing and operation of candy. Its main products are: Manyan shuning brand Qinghou Liyan granules, Guilong Kechuanning capsule, xinbiochemical granules, compound Bupleurum Anshen granules, haoshuangtang, etc. Technological innovation, management innovation, post innovation and market innovation are the driving force of enterprise development. Science and technology personnel account for more than 36% of employees. The technology R & D center and testing center of the company ensure the sustainable development of the company's science and technology and the quality and safety of drugs. Focusing on the field of respiratory system and throat category of traditional Chinese medicine, Guilong has established two domestic brands in the field of respiratory system and throat, "Guilong" brand and "slow, strict, shuning" brand. The aim of Guilong pharmaceutical industry is to "have health, Guilong pharmaceutical industry and health cause"; brand strategy, talent strategy and innovation strategy are the three supports for the development of Guilong; dedication, integrity, responsibility and innovation are the core concepts for the development of Guilong. With the development of enterprises, the existing production and R & D platform of Guilong pharmaceutical industry is not enough to support the rapid and sustainable development of Guilong pharmaceutical industry in the next few years. Therefore, Guilong pharmaceutical industry decided to take hundreds of mu of land in Dangtu Economic Development Zone to build a modern pharmaceutical industrial park integrating biological pharmaceutical production and research and development with domestic professional pharmaceutical technology and process equipment, so as to support Guilong pharmaceutical industry Long's considerable development and technological innovation and scientific and technological progress in the next ten years.

本文链接: https://www.waitui.com/brand/0d765d197.html 联系电话:05556758271

千城特选小程序码

7×24h 快讯

姚伟雄先生将不再担任安踏集团时尚运动品牌群 CEO 职务,江艳女士将接任时尚运动品牌群 CEO

36氪获悉,因已届退休年龄,姚伟雄先生将不再担任安踏集团时尚运动品牌群 CEO 职务,未来他将继续担任集团副总裁,负责集团时尚产业项目的日常管理与运营。自 2010 年起,姚伟雄先生一直负责 FILA品牌大中华地区的业务,带领团队将 FILA 打造成中国时尚运动赛道的标杆品牌,跻身中国前五大运动品牌之列。集团高度肯定姚伟雄先生为公司和行业所做出的杰出贡献,并祝愿他在新的岗位继续发挥更多的才能。 江艳女士将接任时尚运动品牌群 CEO,全面负责时尚运动品牌群的经营管理,继续推动 FILA 夯实“高端时尚运动品牌“的心智定位,实现品牌驱动的业务增长。江艳女士是集团长期培养的年轻梯队干部,拥有丰富的品牌管理经验,曾先后操盘 ANTA KIDS FILA FUSION 的品牌管理工作,实现了两个品牌在细分市场的领先心智。她将领导 FILA 进一步拓展在年轻人群中的影响力,为消费者创造更多的价值。

2小时前

国新创投基金启航 首期规模100亿元

中国国新联合部分中央企业、地方国资1月18日在京共同举行国新创投基金合作签约仪式。国新创投基金出资合作单位有中国五矿、中国钢研、中国建材、中国有研、中国电气装备、杭州资本、兴湘集团等,首期规模100亿元,存续期15年,同时将启动杭州、湖南、西安等一批子基金,通过母子基金放大方式,围绕“国家所需、创新所要、基金所能”,坚持投早、投小、投长期、投硬科技,为科技强国建设和新质生产力培育贡献力量。(财联社)

2小时前

新凤鸣入选首批国家工信部“卓越级智能工厂”

近日,新凤鸣集团“化纤全产业链协同智能工厂”入选国家“卓越级智能工厂(第一批)项目名单(共235家)”,是浙江省上榜的13家企业之一,也是化纤行业唯一上榜企业。(证券时报)

2小时前

先锋集团将支付1.06亿美元以和解美国SEC指控

美国证券交易委员会(SEC)当地时间1月17日在一份新闻稿中指出,先锋集团(The Vanguard Group, Inc.)将支付1.0641亿美元,以和解有关其对资本利得分配和税收影响的误导性陈述的指控,这些误导性陈述影响了在应纳税账户中持有先锋投资者目标退休基金(Investor TRFs)的零售投资者。和解金额将分配给受影响的投资者。(财联社)

2小时前

今年首家!千亿公募换帅

2025年开年,公募基金行业迎来今年首次基金公司换帅。1月18日,兴银基金发布基金行业高级管理人员变更公告,公告显示,易勇新任兴银基金总经理,同时,董事长吴若曼不再代为履行总经理职务。 Wind数据显示,截至2024年9月30日,兴银基金旗下公募产品数量54只,公募管理规模为1067.32亿元。根据银河证券数据显示,近二年固收排名40/129,近三年排名32/119,近五年排名9/93,在权益方面,兴银基金近两年排名进入前10%(12/124)。(券商中国)

2小时前

本页详细列出关于伟思VISHEE的品牌信息,含品牌所属公司介绍,伟思VISHEE所处行业的品牌地位及优势。
咨询